However, when primary engrafted human CD45+ cells from +AML patient samples were transplanted into secondary mice, they generated significantly more engraftment than equivalent numbers of human CD45+ cells from the CD34+-alone group. The gene discussed is CD34; the disease is acute myeloid leukemia.